![The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3 The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/2f52fd893b67a4b776785bd6ba4969459317939a-757x322.png)
The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3
![Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium forPhase II Clinical Trial - Tempus Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium forPhase II Clinical Trial - Tempus](https://prismic-io.s3.amazonaws.com/tempus-20/ab2f0a5f6e3d9312c1a5977c42a0a0acd3acebec_pcctc_081417_article.jpg)
Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium forPhase II Clinical Trial - Tempus
![Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium - Clinical Genitourinary Cancer Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium - Clinical Genitourinary Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/12c255d7-48d6-4463-8eca-68b967648878/gr1_lrg.jpg)
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium - Clinical Genitourinary Cancer
WIRB-Copernicus Group and the Prostate Cancer Clinical Trials Consortium Announce New Partnership to Improve Efficiency of Oncology Research Reviews
![Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials - ScienceDirect Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S258893112030095X-gr2.jpg)
Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials - ScienceDirect
![Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open ... Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/58cc8d22-6bb6-4ac4-a636-b916d923ec69/gr1.jpg)
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open ...
![ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium](https://www.urotoday.com/images/stories/conferences/asco/asco_2014_kim_poster.jpg)
ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium
![Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database - European Urology Focus Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database - European Urology Focus](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2044933010/2056560608/gr1.jpg)
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database - European Urology Focus
![Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 | Journal of Clinical Oncology Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2013.49.34.issue-12/jco.2015.64.2702/20161107/images/medium/jco642702t5.gif)
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 | Journal of Clinical Oncology
![Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials* - Annals of Oncology Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials* - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb446b4f-c6bb-4a8b-9661-21b4b9143db7/gr1.jpg)
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials* - Annals of Oncology
![The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3 The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/55c961810433cc69eba668411f8ba8eb3787e94b-757x650.png)